Journal of Neurology

Article	Citations
Impact of COVID-19 lockdown on sleep quality in university students and administration staff	381
Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms	256
Guillain–Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases	237
Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19)	181
Stroke in patients with SARS-CoV-2 infection: case series	169
A systematic review of neurological symptoms and complications of COVID-19	158
COVID-19-associated acute disseminated encephalomyelitis (ADEM)	150
Guillain-Barré syndrome following COVID-19: new infection, old complication?	140
Immune-mediated neurological syndromes in SARS-CoV-2-infected patients	136
Long COVID: cognitive complaints (brain fog) and dysfunction of the cingulate cortex	112
Clinical manifestations and evidence of neurological involvement in 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis	106
COVID-19 and neurological disorders: are neurodegenerative or neuroimmunological diseases more vulnerable?	99
Acute transverse myelitis after COVID-19 pneumonia	97
The advances of post-stroke depression: 2021 update	95
Neurological and cognitive sequelae of Covid-19: a four month follow-up	89
Neurological manifestations associated with COVID-19: a review and a call for action	88
First case of SARS-COV-2 sequencing in cerebrospinal fluid of a patient with suspected demyelinating disease	88
Autonomic dysfunction in post-COVID patients with and witfhout neurological symptoms: a prospective multidomain observational study	84
Association of neuronal injury blood marker neurofilament light chain with mild-to-moderate COVID-19	76
Rituximab for the treatment of multiple sclerosis: a review	76
Neurological involvement of coronavirus disease 2019: a systematic review	73
Neurologic manifestations in 1760 COVID-19 patients admitted to Papa Giovanni XXIII Hospital, Bergamo, Italy	71
COVID-19 mRNA vaccination leading to CNS inflammation: a case series	71
Reversible Encephalopathy Syndrome (PRES) in a COVID-19 patient	68
Significant reduction of physical activity in patients with neuromuscular disease during COVID-19 pandemic: the long-term consequences of quarantine	68

Management of functional neurological disorder	66
Oxaliplatin-induced peripheral neuropathy: clinical features, mechanisms, prevention and treatment	65
Bell’s palsy following COVID-19 vaccination	65
Effect of melatonin supplementation on sleep quality: a systematic review and meta-analysis of randomized controlled trials	64
Multiple sclerosis and the risk of infection: considerations in the threat of the novel coronavirus, COVID-19/SARS-CoV-2	63
Progression of grey and white matter brain damage in Parkinson's disease: a critical review of structural MRI literature	62
A review of seizures and epilepsy following traumatic brain injury	62
Cognitive, EEG, and MRI features of COVID-19 survivors: a 10-month study	62
Prevalence and impact of COVID-19 in Parkinson’s disease: evidence from a multi-center survey in Tuscany region	61
Antibodies against the node of Ranvier: a real-life evaluation of incidence, clinical features and response to treatment based on a prospective analysis of 1500 sera	60
New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review	60
Treatment of MOG antibody associated disorders: results of an international survey	58
Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients	57
Impact of the COVID-19 outbreak on acute stroke care	57
Association of CNS demyelination and COVID-19 infection: an updated systematic review	55
Digital therapeutics in neurology	55
Central and peripheral nervous system complications of COVID-19: a prospective tertiary center cohort with 3-month follow-up	54
Gastrointestinal dysfunction in Parkinson’s disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation	53
COVID-19 in teriflunomide-treated patients with multiple sclerosis	53
Miller–Fisher-like syndrome related to SARS-CoV-2 infection (COVID 19)	51
Etiologic distribution of dizziness and vertigo in a referral-based dizziness clinic in South Korea	51
The impact of anti-CGRP monoclonal antibodies in resistant migraine patients: a real-world evidence observational study	51
Myoclonus and cerebellar ataxia associated with COVID-19: a case report and systematic review	50
First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine	50
Brainstem neuropathology in two cases of COVID-19: SARS-CoV-2 trafficking between brain and lung	49
Post-COVID-19 fatigue: the contribution of cognitive and neuropsychiatric symptoms	49
Blood neurofilament light concentration at admittance: a potential prognostic marker in COVID-19	49
Mesenchymal stem cell therapy for ischemic stroke: A look into treatment mechanism and therapeutic potential	47
A review of pathophysiology and neuropsychiatric manifestations of COVID-19	45
Nusinersen treatment significantly improves hand grip strength, hand motor function and MRC sum scores in adult patients with spinal muscular atrophy types 3 and 4	45
Psychological consequences of COVID-19 pandemic in Italian MS patients: signs of resilience?	45
Mononeuritis multiplex: an unexpectedly frequent feature of severe COVID-19	44
Neurological manifestations of patients infected with the SARS-CoV-2: a systematic review of the literature	44
Acute transverse myelitis following SARS-CoV-2 vaccination: a case report and review of literature	44
Guillain-Barré syndrome in the COVID-19 era: just an occasional cluster?	43
Managing disorders of consciousness: the role of electroencephalography	43
Levodopa challenge test: indications, protocol, and guide	43
A wearable sensor identifies alterations in community ambulation in multiple sclerosis: contributors to real-world gait quality and physical activity	43
An atlas on risk factors for multiple sclerosis: a Mendelian randomization study	43
Neurofilaments in progressive multiple sclerosis: a systematic review	42
Natural history of most common spinocerebellar ataxia: a systematic review and meta-analysis	42
Why do SARS-CoV-2 NSPs rush to the ER?	42
Anti-CD20 therapies for multiple sclerosis: current status and future perspectives	42
Burden of disease in myasthenia gravis: taking the patient’s perspective	42
COVID-19: dealing with a potential risk factor for chronic neurological disorders	42
Mixed central and peripheral nervous system disorders in severe SARS-CoV-2 infection	41
Clinical and pathological features in adult-onset NIID patients with cortical enhancement	41
Neurological comorbidity and severity of COVID-19	41
Update on benign paroxysmal positional vertigo	40
Ischemic stroke associated with COVID-19: a systematic review and meta-analysis	40

Diagnosing vestibular hypofunction: an update	39
Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensus	39
Bickerstaff encephalitis after COVID-19	39
Nerve ultrasound in hereditary transthyretin amyloidosis: red flags and possible progression biomarkers	38
Post-infectious Guillain–Barré syndrome related to SARS-CoV-2 infection: a case report	38
Transverse myelitis related to COVID-19 infection	38
The emotional impact of the COVID-19 pandemic on individuals with progressive multiple sclerosis	38
Wearable sensors can reliably quantify gait alterations associated with disability in people with progressive multiple sclerosis in a clinical setting	37
Alzheimer’s disease clinical trial update 2019–2021	37
Routine diagnostics for neural antibodies, clinical correlates, treatment and functional outcome	37
SARS-CoV-2-related encephalitis with prominent parkinsonism: clinical and FDG-PET correlates in two patients	36
Acute and post-acute neurological manifestations of COVID-19: present findings, critical appraisal, and future directions	36
Primary or secondary chronic functional dizziness: does it make a difference? A DizzyReg study in 356 patients	36
CNS penetration of potential anti-COVID-19 drugs	36
Bilateral vestibulopathy: beyond imbalance and oscillopsia	36
Neural mechanisms underlying state mental fatigue in multiple sclerosis: a pilot study	36
Cell-based assays for the detection of MOG antibodies: a comparative study	36
Critical illness-associated cerebral microbleeds for patients with severe COVID-19: etiologic hypotheses	35
The Italian multicenter experience with edaravone in amyotrophic lateral sclerosis	35
Treatment expectations and patient-reported outcomes of nusinersen therapy in adult spinal muscular atrophy	35
Early and unrestricted access to high-efficacy disease-modifying therapies: a consensus to optimize benefits for people living with multiple sclerosis	34
Are some patient-perceived migraine triggers simply early manifestations of the attack?	34
Seizures in Alzheimer’s disease are highly recurrent and associated with a poor disease course	34
Impact of COVID-19 on U.S. and Canadian neurologists’ therapeutic approach to multiple sclerosis: a survey of knowledge, attitudes, and practices	34
Acute polyradiculoneuritis with locked-in syndrome in a patient with Covid-19	34
COVID-19 encephalopathy: detection of antibodies against SARS-CoV-2 in CSF	34
An update on idiopathic intracranial hypertension in adults: a look at pathophysiology, diagnostic approach and management	34
Immediate high-dose intravenous immunoglobulins followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19-adenoviral vector vaccine-induced immune thrombotic thrombocyto	33
Neurological updates: neurological complications of CAR-T therapy	33
Axonal variants of Guillain–Barré syndrome: an update	33
Telerehabilitation in response to constrained physical distance: an opportunity to rethink neurorehabilitative routines	32
Long-term efficacy and safety of alemtuzumab in patients with RRMS: 12-year follow-up of CAMMS223	32
Risk factors for benign paroxysmal positional vertigo recurrence: a systematic review and meta-analysis	32
Cerebral venous sinus thrombosis associated with COVID-19: a case series and literature review	31
MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature	31
A global view of comorbidity in multiple sclerosis: a systematic review with a focus on regional differences, methodology, and clinical implications	31
Prevalence of freezing of gait in Parkinson’s disease: a systematic review and meta-analysis	31
Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimod	31
The cerebellar cognitive affective syndrome scale reveals early neuropsychological deficits in SCA3 patients	30
Wearables in the home-based assessment of abnormal movements in Parkinson’s disease: a systematic review of the literature	30
PERMIT study: a global pooled analysis study of the effectiveness and tolerability of perampanel in routine clinical practice	30
Central retina changes in Parkinson’s disease: a systematic review and meta-analysis	30
COVID‐19 in dimethyl fumarate‐treated patients with multiple sclerosis	30
Vestibular evoked myogenic potentials in vestibular migraine and Menière’s disease: cVEMPs make the difference	30
A systematic review and meta-analyses of pregnancy and fetal outcomes in women with multiple sclerosis: a contribution from the IMI2 ConcePTION project	29
Frontal encephalopathy related to hyperinflammation in COVID-19	29
Plasma neurofilament light chain as a biomarker of Alzheimer’s disease in Subjective Cognitive Decline and Mild Cognitive Impairment	29
Progression of sleep disturbances in Parkinson’s disease: a 5-year longitudinal study	29
Multifocal laminar cortical brain lesions: a consistent MRI finding in neuro-COVID-19 patients	29
COVID-19 and neuroinflammation: a literature review of relevant neuroimaging and CSF markers in central nervous system inflammatory disorders from SARS-COV2	29
SARS-CoV-2-associated acute disseminated encephalomyelitis: a systematic review of the literature	28
Enlarged perivascular spaces in multiple sclerosis on magnetic resonance imaging: a systematic review and meta-analysis	28
Acute vestibular syndrome: is skew deviation a central sign?	28
Predictors of cognitive impairment in Parkinson’s disease: a systematic review and meta-analysis of prospective cohort studies	28
What has caused the fall in stroke admissions during the COVID-19 pandemic?	28
Systematic literature review of burden of illness in chronic inflammatory demyelinating polyneuropathy (CIDP)	28
Hematopoietic stem cell transplantation for chronic inflammatory demyelinating polyradiculoneuropathy	28
‘Minimal symptom expression’ in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab	28
Central positional nystagmus: an update	28
Hearing loss versus vestibular loss as contributors to cognitive dysfunction	27
Long-term outcomes in temporal lobe epilepsy with glutamate decarboxylase antibodies	27
Update cerebellum and cognition	27
Early use of high-efficacy disease‑modifying therapies makes the difference in people with multiple sclerosis: an expert opinion	27
Outcome after surgical treatment of cerebrospinal fluid leaks in spontaneous intracranial hypotension—a matter of time	27
Characteristics of intracerebral haemorrhage associated with COVID-19: a systematic review and pooled analysis of individual patient and aggregate data	27
Mild traumatic brain injury recovery: a growth curve modelling analysis over 2 years	27
Autonomic failure in Parkinson’s disease is associated with striatal dopamine deficiencies	27
Fall prediction in neurological gait disorders: differential contributions from clinical assessment, gait analysis, and daily-life mobility monitoring	27
Intravenous immunoglobulin therapy in COVID-19-related encephalopathy	27
Modern machine-learning can support diagnostic differentiation of central and peripheral acute vestibular disorders	27
Pre-procedural predictive factors of symptomatic intracranial hemorrhage after thrombectomy in stroke	26
Global morbidity and mortality of central nervous system tuberculosis: a systematic review and meta-analysis	26
Recent progress in maintenance treatment of neuromyelitis optica spectrum disorder	26
Transcranial direct current stimulation for post-stroke dysphagia: a systematic review and meta-analysis of randomized controlled trials	26
Autologous haematopoietic stem cell transplantation for refractory stiff-person syndrome: the UK experience	26
Vascular risk factors, white matter lesions and cognitive impairment in Parkinson’s disease: the PACOS longitudinal study	26
Amyotrophic lateral sclerosis patients’ and caregivers' distress and loneliness during COVID-19 lockdown	26
Ultrasonography for the diagnosis of carpal tunnel syndrome: an umbrella review	26
Serological response to SARS-CoV-2 vaccination in multiple sclerosis patients treated with fingolimod or ocrelizumab: an initial real-life experience	26
Neuroimmune disorders in COVID-19	26

Neurological manifestations of COVID-19: a review of what we know so far	26
The changing landscape of optic neuritis: a narrative review	25
Emerging themes in idiopathic intracranial hypertension	25
Heritable and non-heritable uncommon causes of stroke	25
CT angiography vs echocardiography for detection of cardiac thrombi in ischemic stroke: a systematic review and meta-analysis	25
Serum phosphorylated neurofilament heavy-chain levels reflect phenotypic heterogeneity and are an independent predictor of survival in motor neuron disease	25
Bilateral carotid artery dissection in a SARS-CoV-2 infected patient: causality or coincidence?	25
Functional motor phenotypes: to lump or to split?	25
Myelin oligodendrocyte glycoprotein-antibody-associated disorder: a new inflammatory CNS demyelinating disorder	25
Management of patients with neuromuscular disorders at the time of the SARS-CoV-2 pandemic	25
Consciously processing balance leads to distorted perceptions of instability in older adults	25
Real-world application of autologous hematopoietic stem cell transplantation in 507 patients with multiple sclerosis	25
An update on MSA: premotor and non-motor features open a window of opportunities for early diagnosis and intervention	25
Vestibular rehabilitation in Europe: a survey of clinical and research practice	25
Quantitative evaluation of olfactory dysfunction in hospitalized patients with Coronavirus [2] (COVID-19)	24
Impact of comorbid Sjögren syndrome in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders	24
The presymptomatic phase of amyotrophic lateral sclerosis: are we merely scratching the surface?	24
Benign versus malignant Parkinson disease: the unexpected silver lining of motor complications	24
Disruptions of neurological services, its causes and mitigation strategies during COVID-19: a global review	24
Repetitive transcranial magnetic stimulation for post-stroke depression: a randomised trial with neurophysiological insight	24
Exploring the clinical association between neurological symptoms and COVID-19 pandemic outbreak: a systematic review of current literature	24
Histopathology and high-resolution ultrasound imaging for peripheral nerve (injuries)	23
Cytotoxic lesions of the corpus callosum (CLOCCs) associated with SARS-CoV-2 infection	23
A critical review of the pharmacological treatment of REM sleep behavior disorder in adults: time for more and larger randomized placebo-controlled trials	23
Pre-existing cerebrovascular disease and poor outcomes of COVID-19 hospitalized patients: a meta-analysis	23
Risk of acute brain lesions in dizzy patients presenting to the emergency room: who needs imaging and who does not?	23
Longitudinal clinical, cognitive, and neuroanatomical changes over 5 years in GBA-positive Parkinson’s disease patients	23
Monkeypox virus from neurological complications to neuroinvasive properties: current status and future perspectives	23
Neurological update: COVID-19	23
Acute bilateral optic/chiasm neuritis with longitudinal extensive transverse myelitis in longstanding stable multiple sclerosis following vector-based vaccination against the SARS-CoV-2	23
Glymphatic system dysfunction in patients with juvenile myoclonic epilepsy	23
A rise in cases of nitrous oxide abuse: neurological complications and biological findings	22
Biallelic RFC1-expansion in a French multicentric sporadic ataxia cohort	22
Factors affecting adherence to disease-modifying therapies in multiple sclerosis: systematic review	22
Non-epileptic seizures in autonomic dysfunction as the initial symptom of COVID-19	22
Myocardial infarction, stroke and cardiovascular mortality among migraine patients: a systematic review and meta-analysis	22
Manifold learning for amyotrophic lateral sclerosis functional loss assessment	22
RETRACTED ARTICLE: Acute necrotizing myelitis and acute motor axonal neuropathy in a COVID-19 patient	22
Exergames for balance dysfunction in neurological disability: a meta-analysis with meta-regression	22
RFC1 AAGGG repeat expansion masquerading as Chronic Idiopathic Axonal Polyneuropathy	22
Covid-19 and Parkinson’s disease: an overview	22
Factors delaying intravenous thrombolytic therapy in acute ischaemic stroke: a systematic review of the literature	22
Neurological manifestations in 404 COVID-19 patients in Washington State	22
GLP-1 receptor agonists in diabetes for stroke prevention: a systematic review and meta-analysis	22
Contribution of nuclear and mitochondrial gene mutations in mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome	22
Bell’s palsy following a single dose of mRNA SARS-CoV-2 vaccine: a case report	22
Nanoparticles for drug delivery in Parkinson’s disease	22
A multinational consensus on dysphagia in Parkinson's disease: screening, diagnosis and prognostic value	22
Tolerability and safety of dimethyl fumarate in relapsing multiple sclerosis: a prospective observational multicenter study in a real-life Spanish population	21
Neurological complications of COVID-19: a preliminary review	21
Impact of comorbidities and co-medication on disease onset and progression in a large German ALS patient group	21
A rare case of acute motor axonal neuropathy and myelitis related to SARS-CoV-2 infection	21
Pathological neural networks and artificial neural networks in ALS: diagnostic classification based on pathognomonic neuroimaging features	21
Cerebral involvement in COVID-19 is associated with metabolic and coagulation derangements: an EEG study	21
Neurological features in SARS-CoV-2-infected patients with smell and taste disorder	21
The natural history of primary progressive aphasia: beyond aphasia	21
Capturing vertigo in the emergency room: three tools to double the rate of diagnosis	21
Acute inflammatory demyelinating polyneuritis in association with an asymptomatic infection by SARS-CoV-2	21
Prevention of recurrent benign paroxysmal positional vertigo with vitamin D supplementation: a meta-analysis	21
Overlapping syndrome of MOG-IgG-associated disease and autoimmune GFAP astrocytopathy	21
Cerebrovascular manifestations in hematological diseases: an update	20
Axonal degeneration in Guillain–Barré syndrome: a reappraisal	20
Vaccines and myasthenia gravis: a comprehensive review and retrospective study of SARS-CoV-2 vaccination in a large cohort of myasthenic patients	20
Cerebrospinal fluid biomarkers and cognitive functions at multiple sclerosis diagnosis	20
Differential effects of sex on longitudinal patterns of cognitive decline in Parkinson’s disease	20
Exacerbation of myasthenia gravis following corticosteroid treatment: what is the evidence? A systematic review	20
Cognitive impairment in temporal lobe epilepsy: contributions of lesion, localization and lateralization	20
Incidence, prevalence and disability associated with neurological disorders in Italy between 1990 and 2019: an analysis based on the Global Burden of Disease Study 2019	20
Polyradiculoneuropathy induced by immune checkpoint inhibitors: a case series and review of the literature	20
The idiopathic intracranial hypertension prospective cohort study: evaluation of prognostic factors and outcomes	20
The sleep and circadian problems of Huntington’s disease: when, why and their importance	20
Impaired connectivity within neuromodulatory networks in multiple sclerosis and clinical implications	20
Neurological update: use of cardiac troponin in patients with stroke	20
Clinical efficacy of the enzyme replacement therapy in patients with late-onset Pompe disease: a systematic review and a meta-analysis	20
Efficacy and safety of N-acetyl-l-leucine in Niemann–Pick disease type C	20
Influence of heavy metals in Parkinson’s disease: an overview	20
A systematic review of non-motor symptom evaluation in clinical trials for amyotrophic lateral sclerosis	20
COVID-19 in Parkinson’s disease: what holds the key?	20
STIG study: real-world data of long-term outcomes of adults with Pompe disease under enzyme replacement therapy with alglucosidase alfa	20
Most degenerative cervical myelopathy remains undiagnosed, particularly amongst the elderly: modelling the prevalence of degenerative cervical myelopathy in the United Kingdom	20
Gadolinium enhancement on cranial MRI in multiple sclerosis is age dependent	19
Seizures associated with antibodies against cell surface antigens are acute symptomatic and not indicative of epilepsy: insights from long-term data	19
Neurologic complications of Down syndrome: a systematic review	19
Expansion of the dimensions in the current management of acute ischemic stroke	19
Trazodone improves obstructive sleep apnea after ischemic stroke: a randomized, double-blind, placebo-controlled, crossover pilot study	19
Does prior administration of rtPA influence acute ischemic stroke clot composition? Findings from the analysis of clots retrieved with mechanical thrombectomy from the RESTORE registry	19
Respiratory function during enzyme replacement therapy in late-onset Pompe disease: longitudinal course, prognostic factors, and the impact of time from diagnosis to treatment start	19
A systematic review and meta-analysis of voxel-based morphometric studies of migraine	19
The impact of device-assisted therapies on the gut microbiome in Parkinson’s disease	19
Surgical techniques and functional evaluation for vestibular lesions in the mouse: unilateral labyrinthectomy (UL) and unilateral vestibular neurectomy (UVN)	19
Do patients with large vessel occlusion ischemic stroke harboring prestroke disability benefit from thrombectomy?	19
Outcomes of a 5-week individualised MDT outpatient (day-patient) treatment programme for functional neurological symptom disorder (FNSD)	19
Neurological update: dizziness	19
Discontinuation and dose reduction of rituximab in relapsing–remitting multiple sclerosis	19
Functional neurological disorder and multiple sclerosis: a systematic review of misdiagnosis and clinical overlap	19